30 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Discovery, Inc. DISCB shares climbed 37.3% to $102.99.
• Grupo Televisa, S.A.B. TV shares climbed 22.4% to $12.39 after the company reached an agreement with Univision to sell its content and media assets in a deal valued at $4.8 billion. Televisa will receive $3 billion in cash and $1.5 billion in Univision equity.
• Kelly Services, Inc. KELYB surged 21.8% to $32.29.
• GameStop Corp. GME jumped 20.2% to $169.45. GameStop said Tuesday it is redeeming senior notes worth $216.4 million that were due in two years that would leave the company mostly debt-free.
• Centennial Resource Development, Inc. CDEV gained 19.3% to $4.82. Shares of energy companies and oil-related stocks traded higher after a spike in crude futures following EIA data, which showed a 5.889M barrel build for April 9th. Additionally, EIA earlier raised its demand outlook for crude.
• Nurix Therapeutics, Inc. NRIX rose 17.8% to $31.30 after Berenberg initiated coverage on the stock with a Buy rating.
• Kymera Therapeutics, Inc. KYMR surged 15.5% to $35.89 after Berenberg initiated coverage on the stock with a Buy rating.
• Takung Art Co., Ltd. TKAT gained 15% to $27.51.
• Galectin Therapeutics Inc. GALT gained 14.8% to $2.4850 after the company announced that a paper in the peer-reviewed Journal for ImmunoTherapy of Cancer (JITC) published data from an ongoing Phase 1 trial evaluating Galectin's belapectin in head & neck cancer, lung cancer, and melanoma.
• Great Elm Group, Inc. GEG gained 14.7% to $2.81.
• DBV Technologies S.A. DBVT gained 14.1% to $6.72.
• UP Fintech Holding Limited TIGR surged 14% to $20.49.
• C3.ai, Inc. AI gained 13.6% to $71.60.
• Callon Petroleum Company CPE surged 10.8% to $37.83. Shares of energy companies and oil-related stocks traded higher after a spike in crude futures following EIA data, which showed a 5.889M barrel build for April 9th. Additionally, EIA earlier raised its demand outlook for crude.
• Longboard Pharmaceuticals, Inc. LBPH rose 8.6% to $12.88 after dropping around 9% on Tuesday.
• FLEX LNG Ltd. FLNG rose 8.6% to $9.83.
• Bit Digital, Inc. BTBT rose 7.3% to $16.39.
• NLS Pharmaceutics AG NLSP shares rose 5.6% to $3.40 after dropping over 13% on Tuesday. NLS Pharmaceutics recently appointed Silvia Panigone, Ph.D. as Chief Operating Officer.

Check out these big penny stock gainers and lose rs

Losers

• LifeMD, Inc. LFMD shares tumbled 18.6% to $9.64 following recent tweets from short seller, Culper Research, including 'We're short LifeMD, Inc. $LFMD...'
• Tian Ruixiang Holdings Ltd TIRX fell 13.7% to $15.76.
• Avenue Therapeutics, Inc. ATXI fell 12.8% to $4.7250. Avenue Therapeutics shares tumbled 24% on Tuesday after the company announced FDA is still reviewing its NDA resubmission for IV tramadol and has not provided a decision.
• CorMedix Inc. CRMD dropped 12.3% to $8.22. CorMedix said it met with the FDA to discuss proposed resolutions for deficiencies in CRL for DefenCath NDA.
• Cleveland BioLabs, Inc. CBLI fell 12.1% to $6.11. Cleveland BioLabs joint venture Genome Protection highlighted publication of TLR5 agonist, GP532 in Communications Biology.
• Pintec Technology Holdings Limited PT fell 12% to $1.170 after declining around 8% on Tuesday. Pintec Technology recently announced it would acquire Jishengtai to expand its fully digitized securities brokerage and wealth management platform.
• Intrusion Inc. INTZ fell 11.5% to $25.00 following earlier short report from White Diamond Research 'Why A Cybersecurity Expert Calls Intrusion And Its New Shield Product "Garbage" As Insiders Liquidate Holdings.'
• Praxis Precision Medicines, Inc. PRAX dropped 11.1% to $27.00. Praxis Precision Medicines received Orphan Drug designation for PRAX-562 for the treatment of SCN8A-DEE.
• Bed Bath & Beyond Inc. BBBY fell 8.8% to $25.46 after the company reported worse-than-expected Q4 sales results. The company also reaffirmed its FY21 sales guidance below analyst estimates.
• Auris Medical Holding Ltd. EARS fell 8.1% to $3.95. Auris Medical recently announced positive preclinical and clinical outcomes with AM-301.
• SeaChange International, Inc. SEAC fell 7.2% to $1.2718 after the company reported Q4 results.
• Canaan Inc. CAN fell 7% to $13.60 after gaining 11% on Tuesday. The company recently released Q4 results.